Samuel J, Noujaim A A, MacLean G D, Suresh M R, Longenecker B M
Department of Immunology, University of Alberta, Edmonton, Canada.
Cancer Res. 1990 Aug 1;50(15):4801-8.
The Thomsen-Friedenrich (TF) antigen is a precursor structure of MN blood group antigens and is also expressed by about 90% of human carcinomas. The immunodominant group of TF antigen [beta-galactosyl(1-3)-alpha-N-acetylglactosamine] is present in cryptic form in normal RBC and is revealed by neuraminidase treatment. A murine monoclonal antibody (Mab 49H.8) developed against neuraminidase treated human RBC was reactive against a variety of human tumors. We have characterized the human tumor associated TF antigen detected by this antibody from a human transitional bladder carcinoma cell line (647V), a human colon adenocarcinoma cell line (LS174T), and a pleural effusion fluid of a breast adenocarcinoma patient (PE 89). A heterologous sandwich radioimmunoassay for TF antigen was developed using Mab 49H.8 as the catcher and 125I-peanut agglutinin as the probe. Detergent extracts of 647V and LS174T cells, media conditioned by culturing these cells, and PE 89 were shown to contain the antigen by this assay. The specificity of the antigen capture by Mab 49H.8 in this assay was demonstrated by its selective inhibition by nitrophenyl-beta-D-galactoside, phenyl-beta-D-galactoside, and a TF hapten. Preliminary studies on TF antigen in serum samples using this assay showed that about 53.7% of the carcinoma samples contained an antigen concentration greater than 200 units/ml whereas for 90.9% of the normal samples the antigen concentration was below 200 units/ml. These studies demonstrated that the TF antigen is shed by the tumor cells both in vitro and in vivo. The TF antigen was sensitive to treatment with alkali (0.1 M NaOH for 5 h at 37 degrees C) and periodate (10 mM sodium periodate for 1 h at room temperature), was resistant to acidic pH (50 mM acetate buffer, pH 4.5, for 5 h at 37 degrees C), and could be extracted with perchloric acid (0.6 M for 1 h at 4 degrees C). The antigen was shown to be a high molecular weight glycoprotein (Mr greater than 1,000,000) by gel filtration chromatography. The density of the antigen was estimated to be about 1.35 g/ml by cesium chloride density gradient centrifugation. The antigen could be isolated from conditioned media by a combination of affinity chromatography and gel filtration with an overall purification of about 61,432-fold and a final recovery of 53.2%.(ABSTRACT TRUNCATED AT 400 WORDS)
汤姆森-弗里登里希(TF)抗原是MN血型抗原的前体结构,约90%的人类癌组织也会表达该抗原。TF抗原的免疫显性基团[β-半乳糖基(1-3)-α-N-乙酰半乳糖胺]以隐蔽形式存在于正常红细胞中,经神经氨酸酶处理后会暴露出来。一种针对经神经氨酸酶处理的人类红细胞产生的鼠单克隆抗体(单克隆抗体49H.8)可与多种人类肿瘤发生反应。我们已对通过该抗体检测到的来自人移行性膀胱癌细胞系(647V)、人结肠腺癌细胞系(LS174T)以及一名乳腺腺癌患者的胸腔积液(PE 89)中的人类肿瘤相关TF抗原进行了特性鉴定。利用单克隆抗体49H.8作为捕获剂、125I-花生凝集素作为探针,开发了一种用于TF抗原的异源夹心放射免疫测定法。通过该测定法显示,647V和LS174T细胞的去污剂提取物、培养这些细胞的条件培养基以及PE 89均含有该抗原。在该测定法中,单克隆抗体49H.8对抗原的捕获特异性通过其被对硝基苯基-β-D-半乳糖苷、苯基-β-D-半乳糖苷和一种TF半抗原选择性抑制得以证明。使用该测定法对血清样本中的TF抗原进行的初步研究表明,约53.7% 的癌组织样本中抗原浓度大于200单位/毫升,而90.9% 的正常样本中抗原浓度低于200单位/毫升。这些研究表明,TF抗原在体外和体内均可从肿瘤细胞中脱落。TF抗原对碱处理(0.1 M氢氧化钠,37℃处理5小时)和高碘酸盐处理(10 mM高碘酸钠,室温处理1小时)敏感,对酸性pH(50 mM乙酸盐缓冲液,pH 4.5,37℃处理5小时)有抗性,并且可用高氯酸(0.6 M,4℃处理1小时)提取。通过凝胶过滤色谱法显示该抗原是一种高分子量糖蛋白(分子量大于1,000,000)。通过氯化铯密度梯度离心法估计该抗原的密度约为1.35克/毫升。该抗原可通过亲和色谱和凝胶过滤相结合的方法从条件培养基中分离出来,总体纯化倍数约为61,432倍,最终回收率为53.2%。(摘要截取自400字)